The DOI matches its Crossref record, with a small difference in title or year; 22 of the 22 references it cites were found in a registry or an index.
Comparative Evaluation of the VITEK 2, Disk Diffusion, Etest, Broth Microdilution, and Agar Dilution Susceptibility Testing Methods for Colistin in Clinical Isolates, Including Heteroresistant Enterobacter cloacae and Acinetobacter baumannii Strains
Open accessAbstract
Increasing antibiotic resistance in gram-negative bacteria has recently renewed interest in colistin as a therapeutic option. The increasing use of colistin necessitates the availability of rapid and reliable methods for colistin susceptibility testing. We compared seven methods of colistin susceptibility testing (disk diffusion, agar dilution on Mueller-Hinton [MH] and Isosensitest agar, Etest on MH and Isosensitest agar, broth microdilution, and VITEK 2) on 102 clinical isolates collected from patient materials during a selective digestive decontamination or selective oral decontamination trial in an intensive-care unit. Disk diffusion is an unreliable method to measure susceptibility to colistin. High error rates and low levels of reproducibility were observed in the disk diffusion test. The colistin Etest, agar dilution, and the VITEK 2 showed a high level of agreement with the broth microdilution reference method. Heteroresistance for colistin was observed in six Enterobacter cloacae isolates and in one Acinetobacter baumannii isolate. This is the first report of heteroresistance to colistin in E. cloacae isolates. Resistance to colistin in these isolates seemed to be induced upon exposure to colistin rather than being caused by stable mutations. Heteroresistant isolates could be detected in the broth microdilution, agar dilution, Etest, or disk diffusion test. The VITEK 2 displayed low sensitivity in the detection of heteroresistant subpopulations of E. cloacae . The VITEK 2 colistin susceptibility test can therefore be considered to be a reliable tool to determine susceptibility to colistin in isolates of genera that are known not to exhibit resistant subpopulations. In isolates of genera known to (occasionally) exhibit heteroresistance, an alternative susceptibility testing method capable of detecting heteroresistance should be used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“studies have shown a significant correlation between E-test results and MIC values obtained through broth or agar dilution methods [69, 70].”
From Methods for screening and evaluation of antimicrobial activity: A review of protocols, advantages, and limitations (2024) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,745
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K. P., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,389
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. P. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 573
Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative Bacteria
Evans, M. E., Feola, D. J., & Rapp, R. P. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18426 · Cited by 550
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 549
Gales, A. C., Reis, A. O., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.183-190.2001 · Cited by 381
Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests
MacGowan, A. P., & Wise, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.17 · Cited by 187
Arroyo, L. A. R., García-Curiel, A., Pachón-Ibáñez, M. E., Llanos, A. C., Ruiz, M. T., Pachón, J., & Aznar, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.903-905.2005 · Cited by 130
Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin
Tan, T. Y., & Ng, S. Y. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01708.x · Cited by 126
Cited by
Sorted by citations
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,416
Poirel, L., Jayol, A., & Nordmann, P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-16 · Cited by 1,476
Landman, D., Georgescu, C., Martin, D. A., & Quale, J. M. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-08 · Cited by 573
Enterobacter cloacae Complex: Clinical Impact and Emerging Antibiotic Resistance
Mezzatesta, M. L., Gona, F., & Stefani, S. (2012) · Future Microbiology · doi:10.2217/fmb.12.61 · Cited by 571
Mechanisms and clinical relevance of bacterial heteroresistance
Andersson, D. I., Nicoloff, H., & Hjort, K. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0218-1 · Cited by 513
Antimicrobial heteroresistance: An emerging field in need of clarity
El-Halfawy, O. M., & Valvano, M. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-14 · Cited by 489
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Nang, S. C., Azad, M. A. K., Velkov, T., Zhou, Q. (., & Li, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000020 · Cited by 428
Nicoloff, H., Hjort, K., Levin, B. R., & Andersson, D. I. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0342-0 · Cited by 406
Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Gordon, N. C., & Wareham, D. W. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.024 · Cited by 378
Hossain, T. J. (2024) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2024.00035 · Cited by 392
Hindler, J. A., & Humphries, R. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03385-12 · Cited by 240
Catry, B., Cavaleri, M., Baptiste, K. E., Grave, K., Grein, K., Holm, A., Jukes, H., Liébana, E., Navas, A. L., Mackay, D., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.06.005 · Cited by 237
Chew, K. L., La, M.-V., Lin, R. T. P., & Teo, J. W. P. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00268-17 · Cited by 211
Gordon, N. C., P'ng, K. M. Y., & Wareham, D. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00922-10 · Cited by 192
Clinical Pharmacokinetics and Pharmacodynamics of Colistin
Grégoire, N., Aranzana‐Climent, V., Magréault, S., Marchand, S., & Couet, W. R. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0561-1 · Cited by 192
Halaby, T., al Naiemi, N., Kluytmans, J. A. J. W., van der Palen, J. A. M., & Vandenbroucke‐Grauls, C. M. J. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02634-12 · Cited by 182
Self-citationPelletier, M. R., Casella, L. G., Jones, J. W., Adams, M. D., Zurawski, D. V., Hazlett, K. R. O., Doi, Y., & Ernst, R. K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00865-13 · Cited by 175
Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside
Maria-Neto, S., de Almeida, K. C., Macedo, M. L. R., & Franco, O. L. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.02.017 · Cited by 173
Colistin susceptibility testing by Etest and disk diffusion methods
Galani, I., Kontopidou, F. V., Souli, M., Rekatsina, P. D., Koratzanis, E., Deliolanis, J., & Giamarellou, H. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.01.011 · Cited by 169
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
Falagas, M. E., Karageorgopoulos, D. E., & Nordmann, P. (2011) · Future Microbiology · doi:10.2217/fmb.11.49 · Cited by 167
Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
Bergen, P. J., Landersdorfer, C. B., Zhang, J., Zhao, M., Lee, H. J., Nation, R. L., & Li, J. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.07.010 · Cited by 163
Dafopoulou, K., Zarkotou, O., Dimitroulia, E., Hadjichristodoulou, C. S., Gennimata, V., Pournaras, S., & Tsakris, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00868-15 · Cited by 154
Al‐Tawfiq, J. A., Laxminarayan, R., & Mendelson, M. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.11.415 · Cited by 142
A multiplexed microfluidic platform for rapid antibiotic susceptibility testing
Mohan, R., Mukherjee, A., Sevgen, S. E., Sanpitakseree, C., Lee, J., Schroeder, C. M., & Kenis, P. J. A. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.04.046 · Cited by 139
Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations
Ezadi, F., Ardebili, A., & Mirnejad, R. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01390-18 · Cited by 147
Polymyxin B versus colistin: an update
Cai, Y., Lee, W., & Kwa, A. L. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1093933 · Cited by 138
Polymyxin Resistance in Gram-negative Pathogens
Srinivas, P., & Rivard, K. R. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0596-3 · Cited by 140
Confronting multidrug-resistant Acinetobacter baumannii: a review
Neonakis, I., Spandidos, D. A., & Petinaki, E. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.014 · Cited by 120
Rodríguez, C. H., Bombicino, K. A., Granados, G., Nastro, M., Carlos, V., & Angela, F. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.05.019 · Cited by 116
Shi, M. Q., Kretlow, J. D., Nguyen, A., Young, S. W., Baggett, L. S., Wong, M. E., Kasper, F. K., & Mikos, A. G. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.112 · Cited by 119
Susceptibility Testing of the Polymyxins: Where Are We Now?
Humphries, R. M. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1505 · Cited by 97
Cluster-dependent colistin hetero-resistance inEnterobacter cloacaecomplex
Guérin, F., Isnard, C., Sinel, C., Morand, P., Dhalluin, A., Cattoir, V., & Giárd, J.-C. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw260 · Cited by 96
Sherry, N. L., & Howden, B. P. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1453807 · Cited by 94
Jayol, A., Nordmann, P., Lehours, P., Poirel, L., & Dubois, V. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.06.002 · Cited by 90
A review on the current situation and challenges of colistin resistance in poultry production
Apostolakos, I., & Piccirillo, A. (2018) · Avian Pathology · doi:10.1080/03079457.2018.1524573 · Cited by 89
Landman, D., Salamera, J., & Quale, J. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02129-13 · Cited by 89
Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin
Turlej-Rogacka, A., Xavier, B. B., Janssens, L., Lammens, C., Zarkotou, O., Pournaras, S., Goossens, H., & Malhotra‐Kumar, S. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3140-3 · Cited by 88
Liang, C.-A., Lin, Y.-C., Lu, P., Chen, H.-C., Chang, H.-M., & Sheu, C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.10.033 · Cited by 87
Napier, B. A., Band, V. I., Burd, E. M., & Weiss, D. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02432-14 · Cited by 86
Major Variation in MICs of Tigecycline in Gram-Negative Bacilli as a Function of Testing Method
Marchaim, D., Pogue, J. M., Tzuman, O., Hayakawa, K., Lephart, P., Salimnia, H., Painter, T., Zervos, M., Johnson, L. E., Perri, M. B., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00001-14 · Cited by 85
Akers, K. S., Chaney, C., Barsoumian, A. E., Beckius, M. L., Zera, W. C., Yu, X., Guymon, C. H., Keen, E. F., ROBINSON, B. J., Mende, K., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02006-09 · Cited by 84
Maâlej, S., Méziou, M., Rhimi, F., & Hammami, A. (2011) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2011.03145.x · Cited by 80
Antimicrobial Susceptibility Testing: A Primer for Clinicians
Kuper, K. M., Boles, D. M., Mohr, J., & Wanger, A. R. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.11.1326 · Cited by 77
Nicoloff, H., Hjort, K., Andersson, D. I., & Wang, H. H. (2024) · Nature Communications · doi:10.1038/s41467-024-48233-0 · Cited by 79
Liao, W., Cui, Y., Quan, J., Zhao, D., Han, X., Shi, Q., Wang, Q. Q., Jiang, Y., Du, X., Li, X., et al. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106573 · Cited by 69
Lee, S. Y., Shin, J. H., Lee, K., Joo, M. Y., Park, K. H., Shin, M., Suh, S., Ryang, D. W., & Kim, S. H. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00427-13 · Cited by 69
Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?
Vasoo, S. S. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00888-17 · Cited by 69
Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives
Falagas, M. E., & Rafailidis, P. I. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.973 · Cited by 67
Polymyxins: A Review of the Current Status Including Recent Developments
Kwa, A. L., Tam, V. H., & Falagas, M. E. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n10p870 · Cited by 66
Multidrug-resistant Gram-negative infections: the use of colistin
Michalopoulos, A. S., & Karatza, D. C. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.88 · Cited by 64
Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays
Kavanagh, A. M., Ramu, S., Gong, Y., Cooper, M. A., & Blaskovich, M. A. T. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01760-18 · Cited by 62
Boyen, F., Vangroenweghe, F. A. C. J., Butaye, P., Graef, E. D., Castryck, F., Heylen, P., Vanrobaeys, M., & Haesebrouck, F. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.01.010 · Cited by 61
Vourli, S., Dafopoulou, K., Vrioni, G., Tsakris, A., & Pournaras, S. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx186 · Cited by 61
Prim, N., Turbau, M., Rivera, A., Rodríguez-Navarro, J., Coll, P., & Mirelis, B. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.09.008 · Cited by 60
Resolving colistin resistance and heteroresistance in Enterobacter species
Doijad, S. P., Gisch, N., Frantz, R., Kumbhar, B. V., Falgenhauer, J. C., Imirzalioglu, C., Falgenhauer, L., Mischnik, A., Rupp, J., Behnke, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35717-0 · Cited by 64
Wang, X., Kang, Y., Luo, C., Zhao, T., Liu, L., Jiang, X., Fu, R., An, S., Chen, J., Jiang, N., et al. (2014) · mBio · doi:10.1128/mbio.00942-13 · Cited by 64
Katip, W., Rayanakorn, A., Oberdorfer, P., Taruangsri, P., & Nampuan, T. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.05.024 · Cited by 58
Yin, D., Guo, Y. P., Li, M., Wu, W., Tang, J., Liu, Y., Chen, F., Ni, Y., Sun, J., Zhang, H., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04123-z · Cited by 56
Polymyxin susceptibility testing, interpretative breakpoints and resistance mechanisms: An update
Bakthavatchalam, Y. D., Pragasam, A. K., Biswas, I., & Veeraraghavan, B. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.09.011 · Cited by 54
Oostdijk, E. A. N., Smits, L. P., de Smet, A. M. G. A., Hall, M. A. L., Kesecioğlu, J., & Bonten, M. J. M. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2761-3 · Cited by 53
Johura, F., Tasnim, J., Barman, I., Biswas, S. R., Jubyda, F. T., Sultana, M., George, C. M., Camilli, A., Seed, K. D., Ahmed, N., et al. (2020) · Gut Pathogens · doi:10.1186/s13099-020-0345-2 · Cited by 52
Polymyxins: Antimicrobial susceptibility concerns and therapeutic options
Veeraraghavan, B., Jeremiah, S. S., & Baliga, P. (2011) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.83905 · Cited by 51
Singhal, L., Sharma, M., Verma, S., Kaur, R., Britto, X. B., Kumar, S. M., Ray, P., & Gautam, V. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0251 · Cited by 48
Piewngam, P., & Kiratisin, P. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.06.014 · Cited by 47
Development of New Tools to Detect Colistin-Resistance among Enterobacteriaceae Strains
Bardet, L., & Rolain, J. (2018) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2018/3095249 · Cited by 47
Sun, J., Huang, S., Yang, S., Pu, S., Zhang, C.-M., & Zhang, L. P. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.12.013 · Cited by 45
History, Chemistry and Antibacterial Spectrum
Velkov, T., Thompson, P. E., Azad, M. A. K., Roberts, K. D., & Bergen, P. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16373-0_3 · Cited by 43
A simple phenotypic method for screening of MCR-1-mediated colistin resistance
Coppi, M., Cannatelli, A., Antonelli, A., Baccani, I., Pilato, V. D., Sennati, S., Giani, T., & Rossolini, G. M. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.011 · Cited by 42
Rapid Detection of Polymyxin-Resistant Enterobacteriaceae from Blood Cultures
Jayol, A., Dubois, V., Poirel, L., & Nordmann, P. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00918-16 · Cited by 41
Cherkaoui, A., Diene, S. M., Renzoni, A., Emonet, S., Renzi, G., François, P., & Schrenzel, J. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.10.009 · Cited by 41
Van, T. D., Dinh, Q.-D., Vu, P. D., Trung, N. V., Pham, C. V., Dao, T. T., Phung, C. D., Hoang, H. T. T., Tang, N. T., Do, N. T. T., et al. (2014) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2014.05.003 · Cited by 40
Jiménez-Pearson, M. A., Galas, M., Corso, A. C., Hormazábal, J. C., Valderrama, C. D., Marcano, N. S., Ramón-Pardo, P., & Melano, R. G. (2019) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2019.65 · Cited by 46
Deciphering Heteroresistance to Colistin in a Klebsiella pneumoniae Isolate from Marseille, France
Bardet, L., Baron, S. A., Leangapichart, T., Okdah, L., Diene, S. M., & Rolain, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00356-17 · Cited by 40
Quale, J. M., Shah, N., Kelly, P., Babu, E., Bäcker, M., Rosas-Garcia, G., Salamera, J., George, A., Bratu, S., & Landman, D. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0163 · Cited by 39
Lai, C., Chen, Y.-S., Lee, N., Tang, H.-J., Lee, S. S., Lin, C.-F., Lu, P., Wu, J.-J., Ko, W., Lee, W., et al. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s194482 · Cited by 38
Chen, L., Lin, J., Lu, H., Zhang, X., Wang, C., Liu, H., Zhang, X., Li, J., Cao, J., & Zhou, T. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0289-2 · Cited by 38
Srinivas, P., Hunt, L., Pouch, S. M., Thomas, K., Goff, D. A., Pancholi, P., Balada-Llasat, J.-M., & Bauer, K. A. A. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.01.028 · Cited by 37
Yero, D., Huedo, P., Conchillo‐Solé, O., Martínez-Servat, S., Mamat, U., Coves, X., Alegre, F. L., Roca, I., Vilà, J., Schaible, U. E., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01160 · Cited by 38
Evaluation of Vitek®2 performance for colistin susceptibility testing for Gram-negative isolates
Khurana, S., Malhotra, R., & Mathur, P. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa101 · Cited by 35
Webb, H. E., Angulo, F. J., Granier, S. A., Scott, H. M., & Loneragan, G. H. (2017) · F1000Research · doi:10.12688/f1000research.12777.1 · Cited by 34
Colistin resistant Escherichia coli carrying mcr-1 in urban sludge samples: Dhaka, Bangladesh
Islam, A., Rahman, Z., Monira, S., Rahman, M. A., Camilli, A., George, C. M., Ahmed, N., & Alam, M. (2017) · Gut Pathogens · doi:10.1186/s13099-017-0227-4 · Cited by 34
Cain, A. K., Boinett, C. J., Barquist, L., Dordel, J., Fookes, M. C., Mayho, M., Ellington, M. J., Goulding, D., Pickard, D., Wick, R. R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28199-y · Cited by 33
Zwe, Y. H., Chin, S. F., Kohli, G. S., Aung, K. T., Yang, L., & Yuk, H. (2020) · Food Microbiology · doi:10.1016/j.fm.2020.103530 · Cited by 33
Panigrahi, K., Pathi, B. K., Poddar, N., Sabat, S., Pradhan, S. K., Pattnaik, D., Patro, S., & Praharaj, A. K. (2022) · Cureus · doi:10.7759/cureus.28317 · Cited by 33
Epidemiological study of Enterobacteriaceae resistance to colistin in Sfax (Tunisia)
Maalej, S. M., Méziou, M., Mahjoubi, F., & Hammami, A. (2012) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2012.04.008 · Cited by 32
Sınırtaş, M., Akalın, H., & Gedikoğlu, S. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.12.012 · Cited by 31
Rechenchoski, D. Z., Dambrozio, A. M. L., Vivan, A. C. P., Schüroff, P. A., Burgos, T. D. N., Pelisson, M., Perugini, M. R. E., & Vespero, E. C. (2017) · Brazilian Journal of Microbiology · doi:10.1016/j.bjm.2017.01.008 · Cited by 30
Katip, W., Yoodee, J., Uitrakul, S., & Oberdorfer, P. (2021) · Scientific Reports · doi:10.1038/s41598-020-78098-4 · Cited by 30
Jean, S., Liao, C., Sheng, W., Lee, W., & Hsueh, P. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2015.08.024 · Cited by 29
Colistin in burn intensive care: Back to the future?
Azzopardi, E., Boyce, D. E., Thomas, D. W., & Dickson, W. A. (2012) · Burns · doi:10.1016/j.burns.2012.07.015 · Cited by 27
Bakthavatchalam, Y. D. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/27182.10375 · Cited by 27
Sree, R. A., Gupta, A., Gupta, N. R., Veturi, S., Reddy, L. S. K., Begum, M., Etrouth, S., Challa, H. R., Reddy, S. S., Singamsetty, A., et al. (2023) · Infection · doi:10.1007/s15010-023-02094-9 · Cited by 26
Pasterán, F. G., Danze, D., Menocal, A., Cabrera, C., Castillo, I., Albornoz, E., Lucero, C., Rapoport, M., Ceriana, P., & Corso, A. C. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01701-20 · Cited by 26
Lopes, S. P., Jorge, P., Sousa, A. M., & Pereira, M. O. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1863329 · Cited by 27
Polymyxin Susceptibility Testing: a Cold Case Reopened
Jerke, K. H., Lee, M. J., & Humphries, R. M. (2016) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2016.04.003 · Cited by 24
Uechi, K., Tada, T., Shimada, K., Nakasone, I., Kirikae, T., & Fujita, J. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.09.004 · Cited by 24
Tzeng, Y., Berman, Z., Toh, E. C., Bazan, J. A., Turner, A. N., Retchless, A. C., Wang, X., Nelson, D. E., & Stephens, D. S. (2018) · Molecular Microbiology · doi:10.1111/mmi.14153 · Cited by 23
Főldes, A., Székely, E., Voidăzan, S. T., & Dobreanu, M. (2022) · Antibiotics · doi:10.3390/antibiotics11030377 · Cited by 24
Perez, L. R. R. (2015) · Apmis · doi:10.1111/apm.12438 · Cited by 22
Metadata
- Authors
- Lo-Ten-Foe, J. R., de Smet, A. M. G. A., Diederen, B. M. W., Kluytmans, J. A. J. W., & van Keulen, P. H. J.
- Affiliations
- Laboratory for Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands
- University Medical Center Utrecht (NL)
- Amphia Ziekenhuis (NL)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-10
- Volume
- 51
- Issue
- 10
- Pages
- 3726-3730
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2043258
- OpenAlex
- W2142419984
- Cited by
- 242
- References
- 22
- Citations by year
- 2026: 15 · 2025: 10 · 2024: 16 · 2023: 19 · 2022: 14 · 2021: 9 · 2020: 22 · 2019: 16 · 2018: 19 · 2017: 24 · 2016: 13 · 2015: 11 · 2014: 9 · 2013: 11 · 2012: 7
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- colistin, colistin susceptibility testing, heteroresistance, Enterobacter cloacae, Acinetobacter baumannii, disk diffusion, E-test, broth microdilution, agar dilution, VITEK 2, selective decontamination of the digestive tract, intensive care unit, Gram-negative bacteria, antibiotic resistance
- MeSH terms
- Acinetobacter Infections, Agar, Anti-Bacterial Agents, Bacterial Infections, Colistin, Cross Infection, Culture Media, Enterobacteriaceae Infections, Humans, Intensive Care Units, Microbial Sensitivity Tests, Polymyxin B, Enterobacter cloacae, Drug Resistance, Multiple, Bacterial, Acinetobacter baumannii
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review